共 50 条
- [21] Pharmacological treatment of schizophrenia with comorbid substance use disorderEXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 231 - 253Azorin, Jean-MichelSimon, NicolasAdida, MarcBelzeaux, Raoul
- [22] Comorbid posttraumatic stress disorder and substance use disordersPSYCHIATRIC ANNALS, 2001, 31 (05) : 313 - 319Brady, KT
- [23] Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorderEUROPEAN PSYCHIATRY, 2021, 64 : S161 - S161Lahteenvuo, M.Luykx, J.Taipale, H.Mittendorfer-Rutz, E.Tanskanen, A.Batalla, A.Tiihonen, J.
- [24] Neuropsychology of comorbid psychotic and substance use disorder patientsARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2008, 23 (06) : 654 - 654Sheng, X.Binks, I. I. I. S. W.
- [26] Management of comorbid anxiety and substance use disordersPSYCHIATRIC ANNALS, 2001, 31 (04) : 265 - 271Myrick, HBrady, K
- [27] Incomplete discussion of bipolar disorder and comorbid substance use disorder replyLANCET GLOBAL HEALTH, 2019, 7 (07): : E847 - E847Mundt, Adrian P.Baranyi, GergoFazel, Seena
- [28] Diagnosis and Treatment of Comorbid Borderline Personality Disorder and Substance Use DisorderCANADIAN JOURNAL OF ADDICTION, 2018, 9 (03) : 30 - 35Lahaie, Francois-SamuelFraser, Ronald
- [29] CASE-MANAGEMENT FOR PEOPLE WITH COEXISTING SEVERE MENTAL DISORDER AND SUBSTANCE USE DISORDERPSYCHIATRIC ANNALS, 1994, 24 (08) : 427 - 431DRAKE, RENOORDSY, DL
- [30] Personality trait may modify the people with antisocial personality disorder from prison to comorbid with substance use or notEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S482 - S483Hsiao, M. Y.Chang, Y. H.Lu, R. B.